Product
Hematopoetic stem cell infusion
1 clinical trial
1 indication
Indication
Multiple SclerosisClinical trial
Allogeneic Stem Cell Transplantation for the Treatment of Multiple SclerosisStatus: Withdrawn, Estimated PCD: 2024-12-01
1 clinical trial
1 indication